Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$345,898,723
-$202,196,366 QoQ
Shares Held
14,364,565
-26.4% QoQ
Ownership
0.252%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#46
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 62%
None 38%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. PFE ranks #9 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,996,669 | $3,594,294,994 | |
| 2 | JNJ |
Johnson & Johnson
|
13,401,691 | $3,403,627,461 | |
| 3 | ABBV |
AbbVie Inc.
|
11,519,507 | $2,898,768,740 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,387,435 | $2,234,285,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,670,064 | $1,536,729,084 | |
| 6 | AZN |
Astrazeneca PLC
|
6,095,430 | $1,155,815,432 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,618,082 | $962,468,477 | |
| 8 | AMGN |
Amgen Inc
|
1,897,321 | $687,057,877 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $345,898,723 | 14,364,565 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $548,095,089 | 19,519,056 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $457,938,511 | 18,391,105 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $468,147,603 | 18,373,140 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $300,435,721 | 12,394,213 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $296,590,329 | 11,704,433 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $394,295,117 | 14,862,236 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $583,494,006 | 20,162,198 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $510,721,175 | 18,253,080 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $514,490,659 | 18,540,204 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $596,799,768 | 20,729,412 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $414,830,088 | 12,506,183 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $825,476,135 | 22,504,802 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $953,094,566 | 23,360,161 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $1,152,735,363 | 22,496,787 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $972,989,156 | 22,234,670 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,156,276,431 | 22,053,718 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,170,760,116 | 22,614,644 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,077,835,749 | 18,252,934 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $802,473,095 | 18,657,826 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $686,409,360 | 17,528,329 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $649,978,372 | 17,940,336 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $312,460,687 | 8,488,473 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $633,215,705 | 17,253,851 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $599,714,103 | 18,339,862 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $654,595,388 | 20,055,033 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||